Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache
Primary Purpose
Post-Dural Puncture Headache
Status
Completed
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
Theophylline Anhydrous Oral Tablet
Sumatriptan Succinate Oral Tablet
Sponsored by
About this trial
This is an interventional treatment trial for Post-Dural Puncture Headache focused on measuring Post-dural puncture headache, Spinal anesthesia, Sumatriptan, Theophylline
Eligibility Criteria
Inclusion Criteria:
- Patients with NPRS score of ≥ 5
- American Society of Anesthesiologists (ASA) physical status ≤ II
- Age from 21 to 50 years
Exclusion Criteria:
- Patients with NPRS score < 5
- ASA physical status > II
- Age < 21 years or > 50 years
- Pregnant women
- History of; Chronic headache, Cluster headache, Migraine
- History of; Convulsions, Cerebrovascular accident, Previous neurological diseases
- History of peripheral vascular disease (ischemic colitis)
- Signs of meningismus
- Dysrhythmia
- Hypertension
- Ischemic heart disease
- Hyperthyroidism
- Liver or Renal impairment
- Use of selective serotonin reuptake inhibitors (SSRIs)
- Use of ergotamine derivatives in the past 24 hours
- Use of monoamine oxidase inhibitors (MAOIs) in the last two weeks
- Use of any kind of opiates
- Allergy to the study medications
- Any contraindication of oral intake
Sites / Locations
- Damanhour Teaching Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Group T (n=30)
Group S (n=30)
Arm Description
Theophylline group
Sumatriptan group
Outcomes
Primary Outcome Measures
Median and Range of Numeric Pain Rating Scale (NPRS) score [(median (range)]
NPRS measures the severity of PDPH, it is a 11 point scale from 0-10; where 0=No pain and 10=Worst possible pain (before, 2h, 6h, 12h, 18h, 24h, then every 12h till 48h)
Mean and Standard deviation of Numeric Pain Rating Scale (NPRS) score (mean±SD)
NPRS measures the severity of PDPH, it is a 11 point scale from 0-10; where 0=No pain and 10=Worst possible pain (before, 2h, 6h, 12h, 18h, 24h, then every 12h till 48h)
Secondary Outcome Measures
Mean and Standard deviation of PDPH duration (hours) (mean±SD)
Time from PDPH onset till NPRS score ≤ 3
Mean and Standard deviation of Length of hospital stay (days) (mean±SD)
Time from hospital admission till discharge
Number of participants and Rate of Treatment-related side effects
Number of participants and Rate of: Palpitation, Dizziness, Gastric irritation, Nausea/Vomiting, Diarrhea, Warm sensations in the body, Tingling sensation, and Tightness in the chest, throat, neck, or jaws.
Full Information
NCT ID
NCT04257851
First Posted
February 4, 2020
Last Updated
May 31, 2021
Sponsor
Damanhour Teaching Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04257851
Brief Title
Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache
Official Title
Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache: A Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
February 15, 2020 (Actual)
Primary Completion Date
May 15, 2021 (Actual)
Study Completion Date
May 15, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Damanhour Teaching Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Objectives: To compare the safety and efficacy of oral theophylline versus oral sumatriptan in the treatment of post-dural puncture headache (PDPH).
Background: PDPH is the most frequent complication of procedures associated with dural puncture for spinal anesthesia or following accidental dural puncture during epidural anesthesia. Since invasive treatments have known complications, pharmacologic management may be preferable.
Patients and Methods: This was a prospective, randomized, double-blind, phase four clinical trial; carried out on 60 patients presented with PDPH at our hospital. Patients were randomly allocated into two equal groups (30 patients each); group T, received oral theophylline, and group S, received oral sumatriptan.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-Dural Puncture Headache
Keywords
Post-dural puncture headache, Spinal anesthesia, Sumatriptan, Theophylline
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group T (n=30)
Arm Type
Active Comparator
Arm Description
Theophylline group
Arm Title
Group S (n=30)
Arm Type
Active Comparator
Arm Description
Sumatriptan group
Intervention Type
Drug
Intervention Name(s)
Theophylline Anhydrous Oral Tablet
Other Intervention Name(s)
Quibron-T/SR tablets
Intervention Description
Theophylline tablet (150 mg/12h)
Intervention Type
Drug
Intervention Name(s)
Sumatriptan Succinate Oral Tablet
Other Intervention Name(s)
Sumigran tablets
Intervention Description
Sumatriptan tablet (25 mg/12h)
Primary Outcome Measure Information:
Title
Median and Range of Numeric Pain Rating Scale (NPRS) score [(median (range)]
Description
NPRS measures the severity of PDPH, it is a 11 point scale from 0-10; where 0=No pain and 10=Worst possible pain (before, 2h, 6h, 12h, 18h, 24h, then every 12h till 48h)
Time Frame
48 hours after initiation of treatment
Title
Mean and Standard deviation of Numeric Pain Rating Scale (NPRS) score (mean±SD)
Description
NPRS measures the severity of PDPH, it is a 11 point scale from 0-10; where 0=No pain and 10=Worst possible pain (before, 2h, 6h, 12h, 18h, 24h, then every 12h till 48h)
Time Frame
48 hours after initiation of treatment
Secondary Outcome Measure Information:
Title
Mean and Standard deviation of PDPH duration (hours) (mean±SD)
Description
Time from PDPH onset till NPRS score ≤ 3
Time Frame
48 hours after initiation of treatment
Title
Mean and Standard deviation of Length of hospital stay (days) (mean±SD)
Description
Time from hospital admission till discharge
Time Frame
48 hours after initiation of treatment
Title
Number of participants and Rate of Treatment-related side effects
Description
Number of participants and Rate of: Palpitation, Dizziness, Gastric irritation, Nausea/Vomiting, Diarrhea, Warm sensations in the body, Tingling sensation, and Tightness in the chest, throat, neck, or jaws.
Time Frame
48 hours after initiation of treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with NPRS score of ≥ 5
American Society of Anesthesiologists (ASA) physical status ≤ II
Age from 21 to 50 years
Exclusion Criteria:
Patients with NPRS score < 5
ASA physical status > II
Age < 21 years or > 50 years
Pregnant women
History of; Chronic headache, Cluster headache, Migraine
History of; Convulsions, Cerebrovascular accident, Previous neurological diseases
History of peripheral vascular disease (ischemic colitis)
Signs of meningismus
Dysrhythmia
Hypertension
Ischemic heart disease
Hyperthyroidism
Liver or Renal impairment
Use of selective serotonin reuptake inhibitors (SSRIs)
Use of ergotamine derivatives in the past 24 hours
Use of monoamine oxidase inhibitors (MAOIs) in the last two weeks
Use of any kind of opiates
Allergy to the study medications
Any contraindication of oral intake
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahmed M Shaat, MD
Organizational Affiliation
Damanhour Teaching Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Damanhour Teaching Hospital
City
Damanhūr
State/Province
El-Beheira
Country
Egypt
12. IPD Sharing Statement
Learn more about this trial
Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache
We'll reach out to this number within 24 hrs